Skip to content

Clinical trials

Phase 2 Bipolar Disorder trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Bipolar Disorder Phase: Phase 2 Country / region: United States Clear all

90 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20014
20023
20034
20043
20054
20066
20075
20086
20093
20113
20124
20133
20141
20153
20162
20174
20185
20192
20201
20225
20233
20245
20254
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed63
Terminated13
Recruiting6
Withdrawn4
Active, not recruiting3
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Institute of Mental Health (NIMH)17
Mclean Hospital6
Forest Laboratories4
Medical University of South Carolina4
The University of Texas Health Science Center, Houston4
Massachusetts General Hospital3
AbbVie2
Johns Hopkins University2
Repligen Corporation2
University of Texas Southwestern Medical Center2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Bipolar Disorder90
Psychotic Disorders16
Mood Disorders15
Mania13
Schizophrenia11
Major Depressive Disorder9
Mental Disorders7
Depressive Disorder5
Alcoholism3
Anxiety Disorders3

Trials

Showing 1 to 25 of 90. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.